Sarah Miller

Associate
Full contact info

Admissions and credentials

New York

Experience

Avid Bioservices Announces $1.1 Billion Acquisition by GHO Capital Partners and Ampersand Capital Partners

November 6, 2024

Cooley advised Avid Bioservices (Nasdaq: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, on its definitive merger agreement to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.

Read more

Related contacts

Bill Sorabella
Partner, New York
Matthew D. Silverman
Special Counsel, Santa Monica
Natalie D. Vernon
Associate, Colorado
Sarah Buchik
Associate, New York
Patrick Reed
Associate, Palo Alto
Alexis Johnson
Associate, Boston
David Silverman
Partner, New York
Baasit Bhutta
Associate, Colorado
Barbara Mirza
Partner, Santa Monica
Austin Holt
Partner, Santa Monica
Tony P. Guan
Associate, Santa Monica
Howard Morse
Partner, Washington, DC
Kathy O'Neill
Partner, Washington, DC
Julia R. Brinton
Associate, Washington, DC
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Elizabeth Caruso
Associate, New York
Sarah Miller
Associate, New York
Eileen Marshall
Partner, Washington, DC
Todd Gluth
Partner, San Diego
Calvin Lee
Associate, New York
Christophe Beauduin
Special Counsel, New York
Charity Williams
Partner, San Diego
Jameson Davis
Associate, Boston
Koji Fukumura
Partner, San Diego
Peter Adams
Partner, San Diego
Michael Egan
Partner, Washington, DC
Gary Warren Hunt III
Associate, Washington, DC
Ellie Seber
Partner, Santa Monica
Alexandra Leavy
Associate, New York
Timothy Nguyen
Special Counsel, San Francisco
Justin Kisner
Special Counsel, Palo Alto
Christopher Kimball
Partner, Washington, DC
Shelby Saunders
Associate, New York
Ross Eberly
Partner, Santa Monica
Joshua Elefant
Associate, Palo Alto
Alanna B Zuchelli
Associate, Reston
Leanne Andrepont
Senior Trademark Paralegal
Megan Boss
Senior Paralegal , Boston

Related Practices & Industries

Septerna Announces Upsized $331.2 Million IPO

November 1, 2024

Cooley advised the underwriters of Septerna, a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery, on its upsized $331.2 million initial public offering.

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Grady Chang
Associate, Santa Monica
Mandy Ching
Associate, London
Megan Drill
Associate, San Diego
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Marjorie Roesser
Associate, San Francisco
Minkyu Park
Associate, New York
Dr. Mark Westwood
Associate, Palo Alto
Hardy Zhou
Associate, New York

Related Practices & Industries

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Mandy Ching
Associate, London
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Associate, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

BioAge Labs Announces $198 Million IPO

September 27, 2024

Cooley advised the underwriters of BioAge Labs, a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases, on its $198 million initial public offering.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Denny Won
Partner, San Francisco
Div Gupta
Partner, New York
Dr. Jon Cousin
Partner, Washington, DC
Lila Hope
Partner, Palo Alto
Xander Lee
Partner, Santa Monica
Joshua Mates
Partner, San Francisco
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
David Peinsipp
Partner, San Francisco
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Tony P. Guan
Associate, Santa Monica
Tony P. Guan
Associate, Santa Monica
Jonathan Kaufman
Associate, Palo Alto
Wyatt Kernell
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Dr. Eric Owens
Associate, New York
Breanna Qin
Associate, Palo Alto
Dr. Xixi Sun
Associate, Boston
Christine Turner
Associate, Colorado
Dr. Mark Westwood
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Daniel Manson
Patent Agent, New York
Robin K. Lee
Paralegal Specialist, Colorado

Related Practices & Industries

HealthCare Royalty and Blue Owl Announce $250 Million Debt Financing With TG Therapeutics

August 6, 2024

Cooley advised Blue Owl Capital (NYSE: OWL), a top asset manager that is redefining alternatives, and HealthCare Royalty (HCRx), a top royalty acquisition company focused on commercial or near-commercial biopharmaceutical products, on a $250 million term loan facility with TG Therapeutics (NASDAQ: TGTX), a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Associate, Chicago
Geoffrey Spolyar
Partner, Boston
Dr. Jon Cousin
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Michael Egan
Partner, Washington, DC
Dr. Heidi A. Erlacher
Partner, Boston
Steve Flores
Partner, Chicago
Phil Mitchell
Partner, New York
Jason Savich
Partner, San Francisco
Daniel Shamah
Partner, New York
Lei Shen
Partner, Chicago
Shimeng Cheng
Special Counsel, San Francisco
Susan Piascik Christoff
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Dr. Jordan Phelan
Associate, Washington, DC
Matt Kong
Associate, San Francisco
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Rodrigo Huerta
Associate, Chicago
Stevie Yu
Associate, New York
Yichao Zhang
Associate, New York

Related Practices & Industries

Memberships and affiliations

American Health Law Association (AHLA)